4.6 Article

Mechanical forces and TGFβ1 reduce podocyte adhesion through α3β1 integrin downregulation

期刊

NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 24, 期 9, 页码 2645-2655

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfp204

关键词

cell adhesion; podocyte; stretch; TGF beta 1; alpha 3 beta 1 integrin

资金

  1. Diabetes UK/Kidney Research UK [ST1/2002]

向作者/读者索取更多资源

Methods. Conditionally immortalized murine podocytes were exposed to mechanical stretch and/or TGF beta 1 for 48 h. Podocyte adhesion, apoptosis and alpha 3 beta 1 integrin expression were assessed. Results. Stretch and TGF beta 1 significantly reduced podocyte adhesion and alpha 3 beta 1 integrin expression, events paralleled by increased apoptosis. Blockade of beta 1 integrin, with a specific antibody, demonstrated a reduced podocyte adhesion indicating that beta 1 integrin downregulation was required for the loss of podocyte adhesion. This was linked to an increase in podocyte apoptosis. The role of apoptosis in podocyte adhesion was further investigated using caspase-3 inhibitors. Podocyte apoptosis inhibition did not affect stretch- and TGF beta 1-mediated integrin downregulation and the loss of podocyte adhesion, suggesting that alpha 3 beta 1 integrin downregulation is sufficient to alter cell adhesion. Although stretch significantly increased podocyte TGF beta type I, II and III receptors but not podocyte TGF beta 1 secretion, the combination of stretch and TGF beta 1 did not show any additive or synergistic effects on podocyte adhesion and alpha 3 beta 1 integrin expression. Conclusions. These results suggest that downregulation of alpha 3 beta 1 integrin expression, by mechanical forces or TGF beta 1, is per se sufficient to reduce podocyte adhesion. Apoptosis may represent a parallel important determinant of the podocyte loss from the GBM.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nutrition & Dietetics

Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project

Daniela Martini, Alice Rosi, Michele Tassotti, Monica Antonini, Margherita Dall'Asta, Letizia Bresciani, Federica Fantuzzi, Valentina Spigoni, Raul Dominguez-Perles, Donato Angelino, Cristian Ricci, Soledad Del Pozo-Luengo, Pedro Luis Tornel, Francesca Scazzina, Angel Gil-Izquierdo, Alessandra Dei Cas, Furio Brighenti, Riccardo Bonadonna, Daniele Del Rio, Pedro Mena

Summary: This study investigated the effects of coffee and cocoa-based products containing coffee on cardiovascular and metabolic risk factors in healthy individuals. Results showed that common dosages of coffee and its substitution with cocoa-based products containing coffee had no significant impact on CM risk factors.

EUROPEAN JOURNAL OF NUTRITION (2021)

Review Cell Biology

The endoplasmic reticulum stress and the unfolded protein response in kidney disease: Implications for vascular growth factors

Carlo Alberto Ricciardi, Luigi Gnudi

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Food Science & Technology

Metabolomic Changes after Coffee Consumption: New Paths on the Block

Claudia Favari, Laura Righetti, Michele Tassotti, Lee Andrew Gethings, Daniela Martini, Alice Rosi, Monica Antonini, Josep Rubert, Claudine Manach, Alessandra Dei Cas, Riccardo Bonadonna, Furio Brighenti, Chiara Dall'Asta, Pedro Mena, Daniele Del Rio

Summary: This study aimed at evaluating the impact of different patterns of coffee intake on endogenous molecular pathways through untargeted metabolomics analysis, identifying 153 discriminant metabolites related to coffee consumption. The results provide new insights into the metabolic routes by which coffee and coffee-related metabolites may exert effects on human health.

MOLECULAR NUTRITION & FOOD RESEARCH (2021)

Article Endocrinology & Metabolism

Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care

M. L. Morieri, N. Vitturi, A. Avogaro, G. Targher, G. P. Fadini

Summary: Type 2 diabetes (T2D) is a major risk factor for metabolic dysfunction-associated fatty liver disease (MAFLD), which is becoming the leading cause of chronic liver disease worldwide. This study found that about three quarters of T2D patients show signs of MAFLD, and higher HSI values are associated with increased prevalence of chronic kidney disease and macroangiopathy. Treatment with dapagliflozin or incretin-based therapies may help improve MAFLD in T2D patients.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)

Article Cell Biology

Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)

Saima Ajaz, Mark J. McPhail, Luigi Gnudi, Francesca M. Trovato, Salma Mujib, Salvatore Napoli, Ivana Carey, Kosh Agarwal

Summary: This study demonstrates for the first time the association of NAFLD progression with mitochondrial dysfunction and changes in metabolites related to the urea cycle. A unique panel of mitochondrial-based signatures was identified to differentiate between stages of NAFLD progression.

MITOCHONDRION (2021)

Article Cardiac & Cardiovascular Systems

Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

V Sciannameo, P. Berchialla, A. Avogaro, G. P. Fadini

Summary: Transposing CVOT results to the population of T2D patients in real-world clinical practice showed that the cardiovascular protective effects of glucose-lowering medications tested in CVOTs can be transferred.

CARDIOVASCULAR DIABETOLOGY (2021)

Review Medicine, General & Internal

Vascular growth factors as potential new treatment in cardiorenal syndrome in diabetes

Carlo Alberto Ricciardi, Luigi Gnudi

Summary: Cardiorenal syndrome in diabetes is characterized by cardiovascular and kidney alterations due to chronic metabolic and hemodynamic perturbations. Imbalance of vascular growth factors plays a crucial role in the progression of vascular dysfunction and organ damage in diabetes-related cardiorenal syndrome.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Nutrition & Dietetics

Effect of Coffee and Cocoa-Based Confectionery Containing Coffee on Markers of DNA Damage and Lipid Peroxidation Products: Results from a Human Intervention Study

Daniela Martini, Raul Dominguez-Perles, Alice Rosi, Michele Tassotti, Donato Angelino, Sonia Medina, Cristian Ricci, Alexandre Guy, Camille Oger, Letizia Gigliotti, Thierry Durand, Mirko Marino, Hans Gottfried-Genieser, Marisa Porrini, Monica Antonini, Alessandra Dei Cas, Riccardo C. Bonadonna, Federico Ferreres, Francesca Scazzina, Furio Brighenti, Patrizia Riso, Cristian Del Bo, Pedro Mena, Angel Gil-Izquierdo, Daniele Del Rio

Summary: The study investigated the effect of consuming different doses of coffee or cocoa-based products containing coffee on markers of DNA damage and lipid peroxidation in young healthy volunteers for one month. Overall, the results showed that consumption of these products did not significantly affect oxidative stress markers, except for a time effect on DNA strand breaks and some markers of lipid peroxidation. Further studies are needed to better explain the findings and understand the impact of different dosages on specific target groups.

NUTRIENTS (2021)

Article Nutrition & Dietetics

Effect of different patterns of consumption of coffee and a cocoa-based product containing coffee on the nutrikinetics and urinary excretion of phenolic compounds

Pedro Mena, Letizia Bresciani, Michele Tassotti, Alice Rosi, Daniela Martini, Monica Antonini, Alessandra Dei Cas, Riccardo Bonadonna, Furio Brighenti, Daniele Del Rio

Summary: Coffee consumption is associated with reduced risk of chronic diseases, and this study investigated the impact of different daily dosages of coffee on plasma and urinary phenolic metabolites. The study found significant differences in the metabolites present in the highest amounts after different patterns of coffee consumption, suggesting that coffee phenolics are more bioavailable than previously thought.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2021)

Article Cardiac & Cardiovascular Systems

Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics

Gloria Cinquegrani, Valentina Spigoni, Federica Fantuzzi, Riccardo C. Bonadonna, Alessandra Dei Cas

Summary: In this study, it was found that stearic acid altered the bioenergetics of human myeloid angiogenic cells, while empagliflozin possibly inhibited mitochondrial respiration to counteract the lipotoxicity induced by stearic acid.

CARDIOVASCULAR DIABETOLOGY (2022)

Article Cell Biology

SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders

Gloria Cinquegrani, Valentina Spigoni, Nicolas Thomas Iannozzi, Vanessa Parello, Riccardo C. Bonadonna, Alessandra Dei Cas

Summary: The glycosylated Spike protein itself does not cause inflammation in human primary M Phi cells, which may be crucial for evading host innate immunity. However, some Spike proteins contaminated with endotoxins can trigger inflammatory responses. In vitro studies with commercially available Spike proteins should be carefully conducted to avoid potential LPS contamination.

CELL BIOLOGY AND TOXICOLOGY (2022)

Review Medicine, General & Internal

Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity?

Paolo Severino, Andrea D'Amato, Silvia Prosperi, Alessandra Dei Cas, Anna Vittoria Mattioli, Antonio Cevese, Giuseppina Novo, Maria Prat, Roberto Pedrinelli, Riccardo Raddino, Sabina Gallina, Federico Schena, Corrado Poggesi, Pasquale Pagliaro, Massimo Mancone, Francesco Fedele

Summary: Heart failure is a multisystemic disease that requires evaluation and treatment based on key parameters such as left ventricular ejection fraction (LVEF). The definition and therapy of HF need to be revised to move away from the old simplistic perspective.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Effect of active vitamin-D on left ventricular mass index: Results of a randomized controlled trial in type 2 diabetes and chronic kidney disease

Luigi Gnudi, Nikolaos Fountoulakis, Angeliki Panagiotou, Antonella Corcillo, Giuseppe Maltese, Maria Flaquer Rife, Ioannis Ntalas, Russell Franks, Amedeo Chiribiri, Salma Ayis, Janaka Karalliedde

Summary: This study explored the effects of active vitamin-D (calcitriol) treatment on left ventricular mass in patients with type-2 diabetes and chronic kidney disease. The results showed that calcitriol treatment did not improve left ventricular mass index. Therefore, the routine use of active vitamin-D does not provide LVMI regression or cardiovascular protection in patients with type-2 diabetes and chronic kidney disease.

AMERICAN HEART JOURNAL (2023)

Article Endocrinology & Metabolism

Efficacy of a training programme for the management of diabetes mellitus in the hospital: A randomized study (stage 2 of GOVEPAZ healthcare)

Alessandra Dei Cas, Raffaella Aldigeri, Valentina Ridolfi, Angela Vazzana, Anna Vittoria Ciardullo, Valeria Manicardi, Alessandra Sforza, Franco Tomasi, Donatella Zavaroni, Ivana Zavaroni, Riccardo C. Bonadonna

Summary: This study assessed the efficacy of a structured educational intervention for health professionals in improving the appropriateness of inpatient diabetes care and clinical outcomes. The results showed that the intervention did not improve the appropriateness of diabetes care or clinical outcomes. In-hospital hypoglycemia was found to be an independent indicator of death risk.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

暂无数据